Company intelligence / Profile preview

Seraphina Therapeutics

San Diego, California, United Statesseraphinatherapeutics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Seraphina Therapeutics has commercialized its lead product "fatty15," a supplement containing the proprietary ingredient FA15™ (C15:0). The company claims mounting scientific evidence supports benefits in cellular function and measurable improvements in cardiometabolic and immune markers within weeks to months. Their approach focuses on replenishing essential micronutrients that decline with age. No traditional pharmaceutical clinical trial results are reported; efficacy data appears to be from preclinical studies and consumer use cases.

Therapeutic areas: OtherCardiovascularImmunology
Modalities: Essential fatty acids (notably C15:0/FA15)micronutrient therapeuticssupplementsfood fortifiers
Industry: Food & Nutrition

Drug pipeline

1 asset

FA15

Commercial

Indications: Cardiovascular disease, Heart failure, Type 2 diabetes, Nonalcoholic fatty liver disease

Partnerships

Genova Diagnostics partnership for at-home Fatty Acid testing kit launch in July 2024; no major pharma partnerships reported yet.

Beyond the preview

Go deeper on Seraphina Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seraphina Therapeutics.

Explore the full profile